Status: Recruiting
A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine
A Phase 3, Randomized, Multi-Center, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Relutrigine in Participants with Developmental and Epileptic Encephalopathies Followed by an Open-Label Extension
Participants needed: 160
Trial details
Phase: Phase 3Age: 2-65Biological sex: AllType: InterventionalSponsor: Praxis Precision MedicinesUpdated: May 11, 2026Locations: 11
Eligibility criteria
Has a documented diagnosis of a developmental and epileptic encephalopathy. [+2]
Has a history of left bundle branch block, arrhythmias, Brugada syndrome, congen... [+5]